Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
- Dot
Unknown
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
This data was developed using the same antibody clone in a different buffer formulation. ab252215
Competitive RNA Dot Blot - Recombinant Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] (ab252215)
Primary antibody dilution : 1 ug/ml
Secondary antibody : Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated
Secondary antibody dilution : 1/20,000
Blocking buffer and dilution buffer : AdvanBlock™ Chemi Blocking buffer
Input : HeLa total RNA 500ng per Dot
Competitive nucleosides :
Lane A : ac4C
Lane B : unmodified C
Exposure time : 137 seconds
This blot was developed using a higher sensitivity ECL substrate
- Dot
Unknown
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
Dot blot analysis of N4-acetylcytidine (ac4C) labeled with either ab252215 at 1/1000 dilution or with methylene blue.
Lane 1 : Total RNA purified from wild-type Hela cells.
Lane 2 : Total RNA purified from NAT10 knockout HeLa cells
Goat Anti-Rabbit IgG H&L (HRP) at 1/100000 dilution was used as secondary antibody.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times : Left panel, 2 minutes. Right panel, 30 seconds.
Knock out of NAT10 (human acetyltransferase) can dramatically reduce ac4C level.
This image was kindly provided by Dr. Jordan Meier, NCI, USA.
This antibody was cited in PMID : 29039931 and 30449621.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab252215).
- Dot
Lab
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
This data was developed using the same antibody clone in a different buffer formulation (ab252215).
Dot blot analysis of N4-acetylcytidine (ac4C) labeled with ab252215 at 1/200 dilution.
Lane 1 : HeLa total RNA
Lane 2 : ac4C RNA oligo
Lane 3 : C RNA oligo
Goat Anti-Rabbit IgG H&L (HRP) Peroxidase conjugated (ab97051) at 1/20,000 dilution was used as secondary antibody.
Ac4C oligo (without biotin labelled) used in the figure was provided by a collaborator.
- Dot
PubMed
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
Dot blot analysis showing effect of hydroxylamine on ac4C in RNA using anti-ac4C antibody. Reaction conditions : 50 mM hydroxylamine, Tris at pH 8.0, 65 °C, 1 hour. Hydroxylamine reduced the detection of ac4C.
Refer to PMID 29039931
Image from Sinclair WR et al., ACS Chemical Biology., 12 (12), 2922-2926. Fig 4C.; doi : 10.1021/acschembio.7b00734.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab252215).
Image from Sinclair WR et al., ACS Chemical Biology., 12 (12), 2922-2926. Fig 4C.; doi: 10.1021/acschembio.7b00734.
- Dot
PubMed
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
Dot blot analysis of total RNA by anti-ac4C found a significantly decreased signal in hydroxylamine-treated samples compared to untreated samples.
Refer to PMID 29039931
Image from Sinclair WR et al., ACS Chemical Biology., 12 (12), 2922-2926. Fig 4F.; doi : 10.1021/acschembio.7b00734.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab252215).
Image from Sinclair WR et al., ACS Chemical Biology., 12 (12), 2922-2926. Fig 4F.; doi: 10.1021/acschembio.7b00734.
- Dot
Unknown
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
Dot blot analysis of N4-acetylcytidine (ac4C) labeled with ab252215 at 1/1000 dilution.
Lane 1 : Synthetic wild type Beta globin RNA probe.
Lane 2 : Synthetic Beta globin RNA probe containing ac4C.
Lane 3 : Synthetic Beta globin RNA probe containing m5C.
Lane 4 : Beta globin RNA probe containing hm5C.
Goat Anti-Rabbit IgG H&L (HRP) at 1/100000 dilution was used as secondary antibody.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 2 seconds.
This antibody shows no cross reactivity with other RNA modifications.
This image was kindly provided by Dr. Jordan Meier, NCI, USA.
This antibody was cited in PMID : 29039931 and 30449621.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab252215).
- Dot
PubMed
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
Dot blot analysis demonstrates concentration-dependent detection of in vitro transcribed ac4C-containing RNAs. The antibody detects RNA probes synthesized in the presence of ac4CTP, but not CTP.
Refer to PMID : 29039931.
Image from Sinclair WR et al., ACS Chemical Biology., 12 (12), 2922-2926. Fig 3C.; doi : 10.1021/acschembio.7b00734.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab252215).
Image from Sinclair WR et al., ACS Chemical Biology., 12 (12), 2922-2926. Fig 3C.; doi: 10.1021/acschembio.7b00734.
- Dot
Unknown
Dot Blot - Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128] - BSA and Azide free (AB253039)
Dot blot analysis of N4-acetylcytidine (ac4C) labeled with ab252215 at 1/1000 dilution.
Lane 1 : Synthetic wild type E. coli tRNA Met probe.
Lane 2 : Synthetic E. coli tRNA Met probe containing ac4C.
Lane 3 : Synthetic E. coli tRNA Met probe containing ac4C pre-treated with 50mM hydroxylamine.
Goat Anti-Rabbit IgG H&L (HRP) at 1/100000 dilution was used as secondary antibody.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 2 seconds.
Hydroxylamine removes the electrophilic acetamide of ac4C.
This image was kindly provided by Dr. Jordan Meier, NCI, USA.
This antibody was cited in PMID : 29039931 and 30449621.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab252215).
Related conjugates and formulations (1)
-
Anti-N4-acetylcytidine (ac4C) antibody [EPRNCI-184-128]
Reactivity data
Product details
ab253039 is the carrier-free version of ab252215.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
N4-acetylcytidine acts to enhance translation fidelity which is essential for accurate gene expression. It ensures the stabilization of RNA structures and impacts the efficiency of translation. This modification often involves an enzyme complex including acetyltransferases which work by transferring the acetyl group from acetyl-CoA to the cytidine residue. Proper functioning and balance of ac4C modifications in RNA depend on these enzymes ensuring that the RNA molecule remains functional and effective in protein synthesis.
Pathways
N4-acetylcytidine takes part in translation and RNA processing pathways. It works alongside RNA polymerase complexes and other enzymes that modify RNA. The modification of ac4C enhances the initiation and elongation phases of translation. Within these pathways it interacts with proteins such as RNA acetylating enzymes and ribosomal proteins to fine-tune these processes ensuring that RNA synthesis and subsequent protein production are precise and efficient.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
CytoJournal 21:68 PubMed39917001
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e70141 PubMed39482983
2024
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 72:103145 PubMed38583415
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:51 PubMed38233839
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 17:e1009940 PubMed34543359
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com